HER2 significance and treatment outcomes after radiotherapy for brain metastases in breast cancer patients. by Wolstenholme, V, Hawkins, M, Ashley, S, Tait, D, Ross, G

HER2 significance and treatment outcomes after radiotherapy for brain metastases in breast cancer patients. by Wolstenholme, V, Hawkins, M, Ashley, S, Tait, D, Ross, G

RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases - results and lessons learnt by Gupta, A, Roberts, C, Tysoe, F, Goff, M, Nobes, J, Lester, J, Marshall, E, Corner, C, Wolstenholme, V, Kelly, C, Wise, A, Collins, L, Love, S, Woodward, M, Salisbury, A, Middleton, M